Literature DB >> 17269912

Iontophoresis - an approach for controlled drug delivery: a review.

Nitin Dixit1, Vikas Bali, Sanjula Baboota, Alka Ahuja, Javed Ali.   

Abstract

The recent approval of lidocaine hydrochloride and epinephrine combined iontophoretic patch (Lidosite Vysteris Inc.) for localized pain treatment by FDA has invigorated the gaining interest in iontophoretic drug delivery systems for the transdermal delivery of drugs. This technique of facilitated movement of ions across a membrane under the influence of an externally applied electric potential difference, is one of the most promising physical skin penetration enhancing method. The rationale behind using this technique is the capability of this method to increase the systemic delivery of high molecular weight compounds with controlled input kinetics and minimum inter-subject variability, which is otherwise achieved only when parentral route of administration is used. Recently, good permeation of larger peptides like insulin has been achieved through this technique in combination with chemical enhancers. This review briefly describes the factors which affect iontophoretic drug delivery and summarizes the studies conducted recently using this technique in order to achieve higher systemic absorption of the drugs having low passive diffusion otherwise. The effect of permeation enhancers (chemical enhancers) on iontophoretic flux of drugs has also been described. Present review also provides an insight into reverse iontophoresis. Various parameters which affect the transdermal absorption of drugs through iontophoresis like drug concentration, polarity of drugs, pH of donor solution, presence of co-ions, ionic strength, electrode polarity etc. have also been reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17269912     DOI: 10.2174/1567201810704010001

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  33 in total

1.  Early effects of corneal collagen cross-linking by iontophoresis in ex vivo human corneas.

Authors:  Rita Mencucci; Stefano Ambrosini; Iacopo Paladini; Eleonora Favuzza; Carlotta Boccalini; Giulia Raugei; Gabriella Barbara Vannelli; Mirca Marini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

Review 2.  Trials and tribulations of skin iontophoresis in therapeutics.

Authors:  Matthieu Roustit; Sophie Blaise; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

3.  Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.

Authors:  Xinyuan Chen; Dilip Shah; Garuna Kositratna; Dieter Manstein; Richard R Anderson; Mei X Wu
Journal:  J Control Release       Date:  2012-01-09       Impact factor: 9.776

Review 4.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

5.  A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery.

Authors:  Birgit Falk Riecke; Else Marie Bartels; Søren Torp-Pedersen; Søren Ribel-Madsen; Henning Bliddal; Bente Danneskiold-Samsøe; Lars Arendt-Nielsen
Journal:  Results Pharma Sci       Date:  2011-11-04

6.  Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa.

Authors:  Ran Wei; Laurent Simon; Longsheng Hu; Bozena Michniak-Kohn
Journal:  Pharm Res       Date:  2011-12-02       Impact factor: 4.200

7.  Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.

Authors:  S Blaise; M Roustit; C Millet; C Ribuot; J Boutonnat; J L Cracowski
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

8.  Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane.

Authors:  Giacomo Bruno; Thomas Geninatti; R Lyle Hood; Daniel Fine; Giovanni Scorrano; Jeffrey Schmulen; Sharath Hosali; Mauro Ferrari; Alessandro Grattoni
Journal:  Nanoscale       Date:  2015-03-12       Impact factor: 7.790

9.  Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.

Authors:  Boaz Amichai; Rachel Mosckovitz; Henri Trau; Orit Sholto; Shirly Ben-Yaakov; Michael Royz; David Barak; Boaz Nitzan; Avner Shemer
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

Review 10.  Physical energy for drug delivery; poration, concentration and activation.

Authors:  Shanmugamurthy Lakshmanan; Gaurav K Gupta; Pinar Avci; Rakkiyappan Chandran; Magesh Sadasivam; Ana Elisa Serafim Jorge; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2013-06-07       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.